SCHEMBL7779486

SCHEMBL7779486

Cn1cc(-c2ccccc2)c(-c2ccc(S(C)(=O)=O)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.58
PTGS1 P23219 4/20 0.57
ALOX5 P09917 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779622 0.88 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL7777709 0.88 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL7780904 0.87 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL7777543 0.87 MAPK13 (0.65) PTGS2PTGS1
SCHEMBL7779957 0.87 CSNK1D (0.65) PTGS2PTGS1
SCHEMBL7780565 0.85 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL5541734 0.84 CSNK1D (0.57)
SCHEMBL8758730 0.82 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL7777498 0.82 PTGS2 (0.68) PTGS2PTGS1
SCHEMBL7779941 0.82 PTGS2 (0.64) PTGS2PTGS1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed